Healthcare > Medical Devices & Equipment
•437 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (437)
%
| Company | Market Cap | Price |
|---|---|---|
|
Surmodics' vascular intervention devices (SurVeil DCB, Pounce thrombectomy, Sublime radial access) are direct Cardiology Devices.
|
$409.39M |
$28.63
-0.62%
|
|
VPG provides precision measurement and diagnostic equipment (measurement systems) used for testing and qualification in various industries.
|
$407.66M |
$30.75
-6.39%
|
|
CYH operates hospitals and a broad network of acute care facilities and outpatient sites, i.e., Hospital Services.
|
$406.89M |
$2.90
-7.05%
|
|
Evolus sells Evolysse injectable HA dermal fillers, a medical devices/biomaterials product category.
|
$395.88M |
$6.14
-1.92%
|
|
Dental equipment category reflecting 3D printing solutions used for dentures and dental devices (NextDent).
|
$394.23M |
$2.89
-9.69%
|
|
Mesa's MassARRAY genomics instrumentation and Gyrolab/protein analysis platforms are diagnostic/clinical lab instruments, aligning with Diagnostic Equipment.
|
$385.97M |
$70.75
+3.12%
|
|
Defibrillators are cardiology-focused medical devices sold by AHG.
|
$383.46M |
$1.60
-6.98%
|
|
Core product category; Delcath's hepatic delivery system falls under vascular intervention devices used for targeted liver therapies.
|
$374.21M |
$10.74
-0.78%
|
|
RxSight directly manufactures and sells Ophthalmology Devices (Light Adjustable Lens system and Light Delivery Device) used in premium cataract surgery.
|
$367.97M |
$9.05
-1.15%
|
|
OMI handles medical device consumables used with devices in healthcare settings, aligning with Medical Device Consumables.
|
$365.45M |
$4.77
-1.24%
|
|
Supply of surgical equipment, including aesthetic laser devices, to a network of clinics.
|
$342.47M |
$3.37
-7.67%
|
|
Medical Imaging tag corresponds to Materialise's Mimics medical imaging software used for planning and analysis.
|
$342.00M |
$5.79
-6.61%
|
|
QuantaFlo is a diagnostic instrument for peripheral arterial disease (PAD), i.e., diagnostic equipment.
|
$340.79M |
$30.56
-2.55%
|
|
Core product is a brain-responsive neuromodulation device (RNS System) used for drug-resistant epilepsy.
|
$337.17M |
$10.28
-5.34%
|
|
Home Health Monitoring Devices: Core home-use medical devices (pneumatic compression devices and AffloVest) used for home therapy.
|
$330.59M |
$14.22
-2.40%
|
|
Core product category is wound care devices, a substantial and investable segment.
|
$320.66M |
$37.48
+8.92%
|
|
MG provides laboratory testing & advisory services as part of asset integrity programs.
|
$312.04M |
$9.96
-2.54%
|
|
Quantum-Si sells diagnostic instruments (Platinum, Proteus platforms) for single-molecule protein sequencing in proteomics.
|
$306.44M |
$1.67
-7.73%
|
|
Autoinjector devices are a core planned delivery system for SCPH's at‑home administration of FUROSCIX.
|
$299.33M |
$5.67
|
|
MPAA distributes/markets diagnostic equipment and test solutions (e.g., JBT-1 bench tester) for engine and EV testing.
|
$296.39M |
$14.89
-2.33%
|
|
Senseonics' Eversense CGM system is a diagnostic/monitoring device used to measure glucose levels.
|
$289.52M |
$0.44
-4.70%
|
|
908 Devices directly manufactures handheld chemical analysis instruments (MX908) and FTIR-based devices (ThreatID, XplorIR) for point-of-need diagnostics, i.e., diagnostic equipment.
|
$286.89M |
$8.00
-9.09%
|
|
Laboratory testing and advisory services offered through LifeMD platform.
|
$280.41M |
$6.17
-5.95%
|
|
Liquid biopsy capabilities (MSK-ACCESS) as part of the diagnostic analytics offerings.
|
$277.71M |
$4.18
-7.32%
|
|
Sanara Surgical includes products and consumables used in surgery (e.g., BIASURGE irrigation), fitting Surgical Equipment.
|
$277.21M |
$31.09
-0.32%
|
|
Ventilator and other home medical equipment rentals/sales align with the Home Health Monitoring Devices category (at-home medical devices).
|
$265.20M |
$6.71
+0.75%
|
|
The company sells proprietary cardiology/interventional devices (MAGiC, MAGiC Sweep, Map-iT, EMAGIN, etc.) directly to hospitals.
|
$264.02M |
$3.07
-9.17%
|
|
Tablo system includes patient/treatment monitoring capabilities and remote data capture, aligning with the patient monitoring category.
|
$260.70M |
$14.52
-1.43%
|
|
Recurring-revenue consumables model around device ecosystems (tips, serums, solutions) aligns with consumables for medical devices.
|
$251.99M |
$1.76
-0.56%
|
|
Symvess is an implantable vascular conduit (prosthetic/implantable device) derived from bioengineered tissue, directly aligning with Prosthetics & Implants.
|
$241.99M |
$1.56
-4.29%
|
|
Installation of a high-speed aseptic isolator filler enables filling of vials, cartridges, and prefilled syringes (Prefillable Syringes).
|
$240.66M |
$6.50
-2.40%
|
|
OraSure directly manufactures and sells diagnostic equipment and self-testing devices (OraQuick self-tests, CT/NG molecular test platform) used for infectious disease diagnostics.
|
$238.61M |
$3.20
+0.31%
|
|
Nanox ARC/X are medical imaging systems, a core product line in the company's business.
|
$228.24M |
$3.90
-5.80%
|
|
Nyxoah directly manufactures and provides the Genio system implant, a surgical medical device used to deliver neurostimulation therapy for obstructive sleep apnea.
|
$219.40M |
$6.38
-6.86%
|
|
Patient monitoring and telemetry features associated with respiratory devices.
|
$219.40M |
$8.16
-4.00%
|
|
Quanterix manufactures ultra-sensitive diagnostic instruments and platforms (HD-1, SR-X, SP-X, HD-X).
|
$219.00M |
$5.64
-6.00%
|
|
Core product line is the PURE EP Platform for intracardiac electrophysiology, fitting under cardiology devices.
|
$215.15M |
N/A
|
|
Directly manufactures and sells surgical equipment in the form of a robotic TKA system and related components.
|
$214.13M |
$6.00
|
|
NIS4 is a non-invasive, blood-based diagnostic modality consistent with the liquid biopsy investable theme.
|
$212.11M |
$4.25
-2.29%
|
|
CVRx directly manufactures and sells Barostim, an implantable neuromodulation device for heart failure, fitting Neuromodulation Devices.
|
$210.41M |
$7.88
+0.51%
|
|
Electromed designs and manufactures medical device components used in its SmartVest HFCWO therapy system.
|
$210.24M |
$25.07
+1.79%
|
|
Utah Medical Products directly manufactures surgical devices such as the Filshie Clip System used in obstetrics/gynecology procedures.
|
$205.35M |
$63.22
+0.51%
|
|
The company emphasizes compatibility with prefilled syringes, a core feature of its delivery platform.
|
$197.94M |
$4.29
+0.23%
|
|
Exagen directly provides autoimmune diagnostic laboratory testing and advisory services via its AVISE CTD platform and related biomarker assays.
|
$197.13M |
$10.95
-0.64%
|
|
InfuSystem is expanding into wound care through partnerships and capabilities, including wound care devices and services.
|
$193.60M |
$9.23
-3.95%
|
|
NexoBrid and EscharEx are enzymatic debridement products used in wound care, aligning with the Wound Care Devices category.
|
$190.99M |
$18.17
+1.34%
|
|
Home Health Monitoring Devices represent the at-home health monitoring product line stemming from HealthBeacon.
|
$188.94M |
$13.80
-2.82%
|
|
Accuray's CyberKnife and TomoTherapy/Radixact platforms incorporate integrated medical imaging for treatment planning and guidance.
|
$184.39M |
$1.72
-3.91%
|
|
NeuroStar Advanced Therapy System is a neuromodulation medical device, representing the core product Neuronetics sells.
|
$183.64M |
$2.79
-5.10%
|
|
RCMT provides advisory and regulatory-support services via its Life Sciences & IT offerings, aligning with Laboratory Testing & Advisory Services.
|
$170.79M |
$23.11
-3.10%
|
|
Insighta FRAGMA liquid biopsy enables multi-cancer early detection, a key diagnostic technology.
|
$169.77M |
$13.89
-3.94%
|
|
Acquisition adds gene editing assessment services and lab testing/advisory offerings.
|
$167.98M |
$1.66
+5.06%
|
|
Growth Direct functions as a diagnostic instrument for microbial detection in QC workflows.
|
$167.56M |
$3.79
+7.37%
|
|
Direct product: DurAVR Transcatheter Heart Valve (TAVR) system in the structural heart/cardiology devices category.
|
$166.25M |
$4.61
-6.11%
|
|
Company directly manufactures ophthalmology devices (OMNI/OMNIEdge, TearCare, SION Surgical Instrument) used in interventional eye care.
|
$165.45M |
$3.20
-5.04%
|
|
TriNav infusion system is a medical device used in embolization procedures, which aligns with Surgical Equipment.
|
$163.46M |
$4.32
-2.26%
|
|
Medical Imaging reflects CT imaging hardware produced via Healthcare asset stream (CT tubes, imaging equipment).
|
$163.04M |
$11.25
-2.43%
|
|
Wound care devices align with first aid and medical product lines.
|
$145.18M |
$38.30
-0.78%
|
|
Profound's flagship TULSA-PRO system uses MRI for image-guided therapy, placing medical imaging at the core of its product.
|
$144.76M |
$5.87
-10.79%
|
|
BabySat and Dream Sock function as real-time patient monitoring devices for infants.
|
$142.77M |
$8.64
-5.47%
|
|
RECELL GO platform and related wound care products are sold as wound care devices/materials, fitting the Wound Care Devices category.
|
$140.50M |
$1.00
|
|
Core product category: ophthalmology devices (surgical laser systems) used for cataract surgery.
|
$140.21M |
$11.89
-1.25%
|
|
Direct product: portable MRI hardware and accompanying imaging software, i.e., medical imaging devices.
|
$136.22M |
$1.75
-13.79%
|
|
RECELL System and its related wound-care products (RECELL GO, RECELL GO mini, Cohealyx, PermeaDerm) are direct medical devices for wound care, fitting the Wound Care Devices category.
|
$135.87M |
$5.14
-6.72%
|
|
OA pain management and cartilage/tendon repair products are orthopedic device offerings.
|
$131.49M |
$9.12
-1.51%
|
|
Mobile phlebotomy and on-site laboratory testing services provided to patients.
|
$125.86M |
$1.27
-1.55%
|
|
EsoCheck is a diagnostic collection device and falls under Diagnostic Equipment.
|
$124.42M |
$1.15
-6.50%
|
|
AVIM therapy and Virtue SAB are cardiovascular medical devices developed by OBIO, thus Cardiology Devices.
|
$120.68M |
$3.15
+8.25%
|
|
SERA provides laboratory testing services for PreTRM and related advisory content.
|
$116.41M |
$2.95
-4.22%
|
|
LIBERTY Endovascular Robotic Surgical System is a surgical device delivering robotic assistance in endovascular procedures.
|
$111.68M |
$3.07
-3.15%
|
|
IMDX develops and sells ddPCR-based diagnostic tests/kits (GraftAssure family) used for organ transplant monitoring.
|
$111.25M |
$3.89
+2.37%
|
|
NNBR produces machined titanium forgings and components used in orthopedic implants (hip replacements), aligning with Orthopedic Devices.
|
$109.47M |
$2.17
-0.91%
|
|
Pro-Dex manufactures autoclavable, battery-powered and electric surgical drivers and shavers, which falls under Surgical Equipment.
|
$108.69M |
$33.33
-4.35%
|
|
The tau proteoform assay and proteomics platform can function as diagnostic‑equipment style offerings in research/clinical contexts.
|
$107.30M |
$0.85
-6.53%
|
|
Medical devices & biometrics context via X5 medical care products and wearables power.
|
$106.62M |
$6.41
-6.01%
|
|
NCSM provides tracer diagnostics hardware/solutions, corresponding to Diagnostic Equipment.
|
$106.18M |
$41.79
-4.41%
|
|
Product is used for medical imaging in radiology (breast health screening) and is FDA-cleared as a software-based medical device.
|
$105.91M |
$3.87
|
|
Patient monitoring functionality via therapy devices and adherence data.
|
$103.85M |
$2.41
-4.37%
|
|
Upright MRI scanners are diagnostic equipment; FONAR manufactures and sells this equipment.
|
$102.87M |
$15.62
-0.27%
|
|
XTNT's core products are orthopedic devices, including spinal implants.
|
$99.70M |
$0.72
-3.30%
|
|
CELLECTRA delivery arrays are single-use consumables as part of the device, fitting Medical Device Consumables.
|
$94.25M |
$2.57
-1.91%
|
|
The platform supports patient monitoring and remote care workflows.
|
$92.01M |
$5.82
-5.98%
|
|
Laboratory testing & advisory services associated with translational oncology and preclinical work.
|
$90.10M |
$6.54
-0.46%
|
|
brPROPHET MRD and MCED platforms are liquid biopsy tests using ctDNA, a direct diagnostic product line.
|
$86.30M |
$8.36
-4.46%
|
|
Healthcare-focused high-value applications, biometrics, and patient-safety integrations align with Medical Devices & Biometrics.
|
$83.37M |
$3.53
-7.11%
|
|
NanoPortal implants are prosthetic/implant devices designed to deliver drugs over an extended period.
|
$81.16M |
$1.37
-2.14%
|
|
Otrexup is an auto-injector device for delivering therapy, signaling the Auto-Injector Devices category.
|
$79.98M |
$0.83
-4.47%
|
|
Focal One robotic HIFU system is a surgical equipment platform used for non-invasive focal therapy, a core product line.
|
$77.07M |
$2.07
-5.91%
|
|
Apyx Medical directly develops and sells surgical devices (Renuvion/J-Plasma technology and the AYON Body Contouring System), i.e., surgical equipment used in aesthetic and surgical procedures.
|
$76.34M |
$2.02
-1.94%
|
|
InspireMD produces carotid stent systems (CGuard Prime) and neuroprotection devices (SwitchGuard NPS) used in CAS/TCAR, directly aligning with Cardiology Devices.
|
$73.22M |
$2.39
-0.90%
|
|
Direct product: Sigyn Therapy is an extracorporeal blood purification device designed to remove pathogens, toxins, and inflammatory mediators.
|
$71.79M |
$2.10
|
|
Laboratory Testing & Advisory Services aligns with WFCF’s auditing, verification, and compliance support.
|
$71.10M |
$13.64
+1.79%
|
|
Wheelchairs and mobility aids are core rehabilitation devices, aligning with Orthopedic Devices.
|
$67.54M |
$0.42
-9.81%
|
|
Laboratory testing and advisory services including testing and regulatory compliance support related to inspection and heat-treating activities.
|
$66.64M |
$14.83
-1.72%
|
|
Revita DMR System is an outpatient endoscopic surgical device used for duodenal modification in metabolic disease.
|
$65.63M |
$1.34
-5.63%
|
|
PhenoImager/PhenoCycler platforms are used for clinical/diagnostic imaging and tissue analysis, aligning with diagnostic equipment.
|
$64.26M |
$1.29
|
|
Zephyr Endobronchial Valve and AeriSeal System are minimally invasive medical devices sold for emphysema treatment.
|
$63.61M |
$1.58
-7.06%
|
|
CytoSorbents' CytoSorb cartridge is a surgical equipment product used in ICU and cardiac surgery; it is a disposable medical device deployed in surgical settings.
|
$61.61M |
$0.98
-0.40%
|
|
Provides diagnostic testing and companion diagnostics services related to patient selection (OncoSignature).
|
$59.89M |
$1.91
+1.60%
|
|
TELA produces OviTex Reinforced Tissue Matrix implants (OviTex PRS, OviTex IHR) for soft tissue reconstruction, a clear fit for the Prosthetics & Implants category.
|
$59.33M |
$1.49
-0.67%
|
Showing page 3 of 5 (437 total stocks)
Loading industry metrics...
Loading comparison data...
